glp-1 bcbs Blue Cross Blue Shield of Massachusetts will stop covering popular drugs for weight loss. Here's why GLP-1 for Weight Loss and
Description
Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to a FAIR Health white paper entitled, Obesity and GLP-1 Drugs: A Claims-Based Analysis
Food and Drug Administration has approved the first drug to treat fatty liver disease, which affects as many as 15 million adults in the United States
What Next?
Commitment to Privacy
During the week of June 15, 2026, FDA issued 25 warning letters to telehealth companies over alleged false or misleading promotional claims about compounded GLP-1 productsclaims the agency views as violating the Federal Food, Drug, and Cosmetic Acts (FDCA) misbranding provisions, including Sections 502(a) and 502(n).
